Basic Information
Alivexis, Inc. is a technology-driven biopharmaceutical company with operational bases in both Japan and the United States. By combining cutting-edge drug discovery platforms, deep insights into disease biology, and a dynamic global business approach, we are advancing our unique portfolio of small molecule drugs alongside various R&D collaborations. Currently, Alivexis is committed to rapidly delivering innovative medicines to patients and families affected by cancer, chronic and acute immune-inflammatory conditions, and rare diseases.